Caryophyllene

Beta-caryophyllene (BCP) holds a unique distinction among cannabis terpenes: it is the only terpene known to directly bind to CB2 cannabinoid receptors in the human endocannabinoid system, effectively making it a dietary cannabinoid. This remarkable property means that caryophyllene can produce anti-inflammatory and pain-relieving effects through the same biological pathway that CBD and other cannabinoids use, but without any psychoactive effects. The FDA has classified caryophyllene as Generally Recognized as Safe (GRAS) for food use, and it is already widely consumed in black pepper, cloves, cinnamon, and oregano. In cannabis, caryophyllene is one of the most prevalent terpenes and contributes the spicy, peppery notes that many strains exhibit. Research published in peer-reviewed journals has demonstrated that caryophyllene can reduce inflammation, alleviate neuropathic pain, and even show potential in treating alcohol dependence by reducing voluntary alcohol intake in animal models. The terpene also shows promise as an anxiolytic, with studies suggesting it can reduce anxiety-like behavior through its action on CB2 receptors. For cannabis consumers, strains high in caryophyllene are often recommended for pain management and inflammation without heavy sedation. Caryophyllene's low boiling point of 130°C makes it one of the first terpenes released when vaporizing cannabis, so low-temperature vaping is ideal for maximizing its benefits.